Epigenetic aging clocks need better trials, says Nature Medicine

A new piece in Nature Medicine argues that current epigenetic aging clocks, which measure biological age, lack robust clinical trials. The article calls for larger, randomized studies to validate these tools before they see wider adoption for health interventions. It’s a call to action for the longevity industry.